“Back in the U.S.A.”: FDA Launches PreCheck Program to Boost Domestic Drug Manufacturing

Chuck Berry’s 1959 hit, “Back in the U.S.A.” came to mind as we reviewed the Food and Drug Administration’s recent move to bolster the resilience of the U.S. pharmaceutical supply chain by introducing the FDA PreCheck program. This initiative aims to enhance regulatory predictability, facilitate the establishment of drug manufacturing sites within the United States, and bring more drug manufacturing back to the U.S….
By: Arnall Golden Gregory LLP